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Abstract The functional interaction of the voltage-gated potas-
sium channel hKv1.5 with the PDZ domain containing protein
SAP97 has been investigated. In marked contrast with the
known dependence of SAP97-induced Kv1 potassium current
down-regulation on the channel C-termini, SAP97 increased
hKv1.5 current through an indirect interaction with the Kv1.5
N-terminus. Deletion of the Kv1.5 N-terminus eliminated the
SAP97-mediated increase in potassium currents whereas dele-
tion of the channel’s C-terminal PDZ binding motif had no
e¡ect. In contrast with other Kv1^SAP97 interactions, no phys-
ical interaction could be detected in vivo or in vitro between the
two proteins. The proteins did not co-localize in cardiac myo-
cytes nor did they co-immunoprecipitate from transfected HEK
cells. Yeast two-hybrid experiments also failed to detect any
interaction between the two proteins, but in one experiment of
six, Kv1.5 co-immunoprecipitated very ine⁄ciently with SAP97
from rat ventricular myocytes. Thus, we conclude that the in-
£uence of SAP97 on Kv1.5 potassium current levels is depen-
dent upon a novel regulatory mechanism.
2 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The targeting of ion channels to their intended cellular lo-
cations is a complex process [1]. Folding and assembly occur
concurrently with the synthesis of the channel proteins in the
endoplasmic reticulum [2^4] and the assembled channels are
then tra⁄cked to their ¢nal destination on the cell surface or
retained in intracellular pools (reviewed in [5]). This transport
or internal retention of the assembled channels is in£uenced
by signal sequences that are undoubtedly recognized by ancil-
lary proteins whose job it is to target the channels to their
programmed locations in the cell [6^8]. For example, a
VXXSL motif present in the Kv1.4 C-terminus allows e⁄cient
tra⁄cking of that channel to the cell surface whereas mutation
to VXXSN (as exists in wild-type Kv1.2) yields channels
that tra⁄c poorly [6]. Pore sequences have also been impli-
cated in channel tra⁄cking [8]. The anchoring of the channels
at their ¢nal destinations requires still other signal sequences.
PSD95, for example, binds an extreme C-terminal motif
present in many ion channels [9^12] and has been shown to
anchor voltage-gated potassium channels at the membrane
[12]. SAP97, another PDZ protein closely related to PSD95,
was found by Ti¡any et al. [12] to retain heterologously ex-
pressed Kv channels in the cell interior and to prevent their
tra⁄cking to the surface. Probably hundreds of PDZ proteins
like PSD95 and SAP97 are expressed in human tissues. A
SMART search of human genome project data [13] turns up
259 potential genes encoding PDZ domains.
Recently, we have found a second PDZ binding domain in
Kv1-type potassium channels [14]. In addition to C-terminal
binding motifs, we found that PSD95 binds an N-terminal
sequence within or very near the T1 assembly domain. Dele-
tion of either binding region profoundly in£uenced the expres-
sion of hKv1.5 in HEK293 cells expressing both the channel
and PSD95. PSD95 is abundant in neurons where it localizes
to the postsynaptic density and associates with a number of
proteins including ion channels (reviewed in [15,16]). PSD95 is
reportedly not present in the heart, however [17]. Instead, a
number of related PDZ proteins are present in that tissue.
One or more of these proteins might well perform a similar
function in in£uencing Kv channel expression in that organ.
Among the many possible cardiac PSD95 analogs are ZASP,
ENH and SAP97 [18^20]. SAP97 is highly homologous to
PSD95 and is abundant in the heart [20]. It has also been
recently reported to co-localize with Kv1.5 in cardiac myo-
cytes and to co-immunoprecipitate with the channel when the
two are co-expressed in COS-7 cells [21]. Singularly among
Kv1 channels, the expression of which is normally down-regu-
lated by SAP97 [11,12], co-expression of Kv1.5 with SAP97
causes a large increase in cellular current levels [21]. We have
further investigated this interaction in an attempt to learn
whether this PDZ protein might also bind the N-terminus
of hKv1.5 in a manner analogous to the hKv1.5^PSD95 in-
teraction. Indeed, we found that SAP97 co-expression signi¢-
cantly increased Kv1.5 currents in transfected HEK cells and
that the N-terminus is essential to this e¡ect. Surprisingly, we
could ¢nd no evidence of binding of the two proteins in trans-
fected HEK293 cells or via yeast two-hybrid assays and scant
evidence for any interaction in heart. Thus, SAP97 modula-
tion of Kv1.5 currents is likely through an indirect mecha-
nism.
2. Materials and methods
2.1. DNA constructs
For expression in HEK293 cells, SAP97 was cloned as an EcoRI
fragment into pcDNA3 (Invitrogen, Carlsbad, CA, USA). For the
yeast two-hybrid assays an EcoRI-BstEII fragment of SAP97 contain-
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ing the three PDZ domains and half of the SH3 domain was cloned
into pGAD424 and sequenced to con¢rm the correct reading frame.
Other constructs were as previously described [14].
2.2. Electrophysiological procedures
Procedures were as previously described [14] except that HEK293
cells stably expressing Kv1.5 were transfected with pGFP and
pcDNA3 or SAP97: :pcDNA and pGFP.
2.3. Myocyte isolation, immunolabeling and imaging
Myocytes were isolated and prepared using the method of Scriven
et al. [22]. Isolated myocytes were ¢xed with 2% paraformaldehyde for
10 min followed by neutralization with glycine bu¡er for 10 min. They
were then washed with phosphate-bu¡ered saline (PBS) for 10 min,
made permeable with 1 Wl/ml PBS Triton X (10 min), washed again
for 10 min with PBS, and ¢nally stored in PBS^azide solution. Cells
were plated onto poly-L-lysine-coated coverslips for a minimum of 3 h
at room temperature or overnight at 4‡C. Myocytes were labeled for
3 h at room temperature or overnight at 4‡C with primary mouse
monoclonal antibodies against SAP97 (1:300, BD Transduction,
San Jose, CA, USA), and rabbit polyclonal antibodies developed in
our laboratory against Kv1.5 (1:300). Secondary Alexa 594-conju-
gated goat anti-mouse and Alexa 488-conjugated goat anti-rabbit
(Molecular Probes, Eugene, OR, USA) antibodies were incubated
for 2 h at room temperature. Cells were washed three times with
PBS prior to mounting with a 90% glycerol, 2.5% w/v DABCO^
PBS solution. Images of labeled cells were taken using a Bio-Rad
Radiance Plus on an inverted Zeiss Axiovert microscope, using Bio-
Rad LaserSharp 2000 software. Images were prepared using NIH
Image and Photoshop Software Packages.
2.4. Co-immunoprecipitations
Co-immunoprecipitations from transfected HEK293 cell lines were
as previously described [14] except that a mouse monoclonal antibody
to SAP97 was employed as appropriate. In cardiac experiments, ex-
cised ventricular or atrial tissue was added to ice-cold non-denaturing
lysis bu¡er (20 mM HEPES, 150 mM NaCl, 2 mM EDTA, 10%
glycerol, 0.5% IGEPAL CA-630, 1% hemoglobin, 10 mM iodoacet-
amide, 1 mM phenylmethylsulfonyl £uoride and 0.2 TIU/ml aproti-
nin), and underwent homogenization, two pulses of 30 s using an
Ultra-Turrax T25 homogenizer (Janke and Kunkel, Staufen, Ger-
many). The lysate was transferred to 1.5 ml Eppendorf tubes and
nuclei and debris pelleted by spinning at 1000Ug for 10 min, the
supernatant was transferred to a fresh tube and pre-cleared twice
with pre-washed CL4B Sepharose beads. The pre-cleared supernatant
was mixed with 3^7 Wl of antibody and incubated on ice for 1 h. Pre-
swelled and washed protein A-Sepharose beads were added to the
lysate/antibody mixture and incubated for 1 h with frequent mixing.
The beads were pelleted and the supernatant removed. Beads were
then washed three times with TSA-T (10 mM Tris pH 8.0, 140 mM
NaCl, 0.1% Triton X-100), once with TSA (10 mM Tris pH 8.0, 140
mM NaCl) and once with 50 mM Tris pH 6.8. Beads were then
suspended in sodium dodecyl sulfate (SDS) sample bu¡er and heated
to 95‡C for 5 min before being run on a 12% SDS^polyacrylamide gel.
Proteins were then transferred to polyvinylidene di£uoride membranes
and probed with either rabbit anti-Kv1.5 (1:10 000; developed in our
lab), mouse anti-SAP97 (1:5000) or mouse anti-actinin (1:10 000, Sig-
ma, St. Louis, MO, USA) and horseradish peroxidase-conjugated
goat anti-rabbit IgG or sheep anti-mouse (1:10 000; Jackson Labora-
tories). Antibody binding was detected using a chemiluminescent re-
agent (Renaissance, New England Nuclear).
2.5. Yeast two-hybrid experiments
Kv1.5 and Kv1.4 N- and C-terminal fragments were cloned into
appropriate pGBD vectors; SAP97 and K-actinin2 were cloned in
pGAD vectors [23]. For two-hybrid growth assays, yeast strain
PJ69-4a was transformed with appropriate pairs of clones. Growth
on media lacking adenine and histidine was monitored to assay for
interaction. L-Galactosidase assays were conducted in the Y190 strain
as previously described, [14].
3. Results
3.1. Co-expression of SAP97 with hKv1.5 enhances hKv1.5
currents in HEK cells
As a ¢rst step towards understanding the role of SAP97 in
Kv1.5 expression, we co-expressed hKv1.5 and SAP97 in
HEK cells. To accomplish this, a SAP97 construct was trans-
fected into HEK293 cells that stably express hKv1.5. Experi-
ments were carried out so that the electrophysiologist was
blinded to the transfection group (SAP97 or vector alone).
As illustrated in Fig. 1, hKv1.5 currents were signi¢cantly
enhanced in the presence of the SAP97 construct 24 h after
transfection. There was no apparent change in the activation
or inactivation time courses of the current. It was found that
peak currents were approximately doubled (from 7.9S 1.4 nA
to 18.6 S 2.3 nA at +60 mV, n=9) 24 h after SAP97 trans-
fection compared to control cells that were transfected with
empty vector (pGFP, n=8). This e¡ect was independent of
the test potential used (Fig. 1). Thus, SAP97 has a signi¢cant
e¡ect on hKv1.5 expression levels in transfected HEK cells, a
result con¢rming in mammalian cells that obtained by Murata
et al. [21] who found that SAP97 co-expression substantially
enhanced Kv1.5 currents in doubly injected Xenopus oocytes.
These electrophysiological data demonstrate a role for
SAP97 in the regulation of hKv1.5 currents at least in heter-
ologous cell systems. The enhancement of hKv1.5 currents
could be due to a direct interaction between SAP97 or to
Fig. 1. E¡ect of SAP97 expression on hKv1.5 peak currents. HEK293 cells stably expressing hKv1.5 were used to test the e¡ect of SAP97 co-
expression on ionic currents. Cells were transiently transfected with either empty vector (pcDNA3)+pGFP or SAP97+pGFP and peak currents
at several voltages were measured under voltage clamp in whole-cell con¢guration using a step voltage clamp protocol illustrated under the cur-
rent tracings. Representative current traces at potentials of 320, 310, 20 and 60 mV are shown, and mean dataSS.E.M. (B) for eight (SAP97)
or nine (pGFP) cells are presented. The asterisks indicate statistical signi¢cance with P6 0.01.
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Fig. 2. SAP97 does not co-localize with Kv1.5 in rat ventricular myocytes. Confocal images of single optical slices of ventricular myocytes.
SAP97 was detected with Alexa594-labeled secondary antibody (red); Kv1.5 was detected with Alexa488-labeled secondary antibody (green).
Yellow indicates co-localization of the channel with SAP97 in the merged image.
Fig. 3. Attempted co-immunoprecipitation of SAP97 and Kv1.5. A: The single example (one of six) of co-immunoprecipitation of SAP97 with
Kv1.5 from rat ventricular extracts. Extracts from ventricular tissue were mixed with no antibody, anti-Kv1.5 or anti-SAP97. The protein^anti-
body complexes were precipitated with protein A-Sepharose and subjected to Western analysis probed with anti-SAP97. B: Kv1.5 and SAP97
fail to co-immunoprecipitate from transfected HEK293 cells. Extracts of SAP97, T7-tagged Kv1.5 double-expressing HEK cells were mixed
with no antibody, anti-T7 or anti-SAP97. The complexes were precipitated with protein A-Sepharose and subjected to Western analysis probing
with anti-T7 (left panel) or anti-SAP97 (right panel). C: PSD95 co-immunoprecipitates with Kv1.5 from transfected HEK cells. Control experi-
ments were conducted as in B except that the HEK cells co-expressed T7-tagged Kv1.5 and GFP-tagged PSD95. PSD95 was immunoprecipi-
tated with anti-GFP. The blot was probed with anti-T7.
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an indirect action, either through a bridging molecule or
through an e¡ect on another molecule or molecules that
somehow regulates hKv1.5 activity. To begin to distinguish
between these possibilities, we conducted co-localization, co-
immunoprecipitation and yeast two-hybrid experiments.
3.2. hKv1.5 and SAP97 fail to co-localize in rat cardiac
myocytes
Co-localization experiments were performed to test whether
hKv1.5 and SAP97 interact in vivo. Confocal images were
obtained of isolated rat ventricular myocytes cross-reacted
with antibodies to hKv1.5 and SAP97. As shown in Fig. 2,
both Kv1.5 and SAP97 were widely distributed in the myo-
cytes. The two molecules co-localized very poorly ^ if at all ^
in these cells, however. Kv1.5 was enriched at the intercalated
disks and SAP97 was generally internal. SAP97 appeared to
be largely distributed along Z-lines
3.3. Kv1.5 co-immunoprecipitations with SAP97 from cardiac
myocytes
In order to further test whether or not Kv1.5 and SAP97
directly interact in atrial and/or ventricular myocytes, we con-
ducted co-immunoprecipitation experiments. We found that
while Kv1.5 and SAP97 were e⁄ciently immunoprecipitated
by their respective antibodies, SAP97 failed to co-immunopre-
cipitate with Kv1.5 in ¢ve of six experiments from ventricular
extracts, although in one experiment out of six, SAP97 did co-
immunoprecipitate very poorly with hKv1.5 (Fig. 3A).
Whether this represents a real interaction or is a one-time
artifact is unclear. We could not detect any co-immunoprecip-
itation of Kv1.5 by antibody to SAP97, nor of SAP97 with
Kv1.5 from atrial extracts (data not shown). These results are
consistent with the lack of co-localization seen in imaging
experiments.
3.4. hKv1.5 fails also to co-immunoprecipitate with SAP97
from transfected HEK cells
While Murata et al. [21] were unable to consistently co-
immunoprecipitate the proteins from the cardiac myocytes,
they were able to co-immunoprecipitate SAP97 and Kv1.5
from transfected COS-7 cells. We therefore decided to test
whether the two proteins could be co-immunoprecipitated
from a highly over-expressed system using transfected HEK
cells. HEK293 cells stably expressing a T7-tagged hKv1.5 con-
struct were transfected with a SAP97 clone in pcDNA3 and
co-immunoprecipitation experiments were conducted. As
shown in Fig. 3B, both hKv1.5 and SAP97 could be readily
immunoprecipitated from these cells. But antibody to one
never brought down the other. This is unlikely to be due to
detergent disruption of the Kv1.5^SAP97 interaction. When
the closely related PDZ protein PSD95 was co-expressed in
place of SAP97, PSD95 readily co-immunoprecipitated with
hKv1.5 (Fig. 3C). Given that the in£uence of SAP97 on
hKv1.5 currents in this cell line is marked, this failure of
the two proteins to bind each other was quite surprising.
3.5. SAP97 interacts with Kv1.4 but not with hKv1.5 in yeast
two-hybrid experiments
In a ¢nal attempt to determine whether we could detect an
interaction under quite di¡erent conditions, we conducted
yeast two-hybrid studies. Yeast strain PJ69-4a [23] was co-
transformed with C- and N-terminal fragments of hKv1.5 or
the C-terminus of Kv1.4 in pGBD and the PDZ domains of
SAP97 in pGAD. As shown in Fig. 4, yeast harboring both
the Kv1.4 C-terminus and the SAP97 construct grew well on
medium lacking adenine and histidine as did another control
in which the hKv1.5 N-terminus was tested against K-actinin2.
Neither the hKv1.5 C- nor N-terminal fragments allowed
growth on the test media. Similar results were obtained
when the constructs were co-transformed into yeast strain
Y190 and L-galactosidase assays were conducted. Only the
Kv1.4 C-terminus/SAP97 and hKv1.5 N-terminus/K-actinin2
combinations yielded L-galactosidase activities above control
(data not shown). While it remains formally possible that
SAP97 directly interacts with an untested fragment of Kv1.5
or with a combination of fragments, these yeast two-hybrid
data are inconsistent with a stereotypical interaction between
the extreme C-terminus of the channel with the PDZ protein.
3.6. SAP97 enhancement of hKv1.5 currents depends on an
intact Kv1.5 N-terminus
The results of all of the experiments described above are
Fig. 4. Yeast two-hybrid assay for the interaction of Kv1.5 N- and
C-terminal interactions with SAP97. The Kv1 channel fragments
were expressed as fusions to the DNA binding domain of the yeast
GAL4 protein. SAP97 and K-actinin2 clones were expressed as fu-
sions to the GAL4 transcription activating domain. Growth on
3ade, 3his medium indicates a detectable interaction. Growth on
3leu, 3trp con¢rms that both fusion vectors are present in the
yeast. ‘Alone’ refers to yeast co-transformed with the reported con-
struct plus its empty vector partner for the yeast two-hybrid assay.
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inconsistent with a typical PDZ^extreme C-terminal interac-
tion between SAP97 and Kv1.5. Instead, SAP97 must exert its
e¡ect by some di¡erent, most likely indirect, mechanism. To
gain further insight into this issue, experiments with hKv1.5
C- and N-terminal deletion mutants were conducted. SAP97
was transfected into HEK293 cells stably expressing either
hKv1.5vETDL or hKv1.5vN209 [24] and potassium currents
were measured as before. The hKv1.5vETDL mutant lacks
the C-terminal four amino acids required for interaction
with PDZ proteins and hKv1.5vN209 lacks the N-termi-
nal 209 amino acids of the channel. Strikingly, it was the
N-terminus and not the C-terminus that proved essential
to the SAP97 enhancement of Kv1.5 potassium currents.
hKv1.5vN209 Kþ currents were not a¡ected at all by
SAP97 co-expression (Fig. 5A) but, as with the wild-type
channel, SAP97 co-expression signi¢cantly increased potassi-
um currents in the vETDL line (Fig. 5B). Again, this e¡ect of
SAP97 on the channel was potential-independent. HEK cells
display a small endogenous potassium current. Conceivably,
the channel subunits that carry this current could heteromul-
timerize with the transfected Kv1.5 subunits and mediate a
SAP97 interaction with those channels. To test this possibility,
similar experiments in CHO and LM6 cells, which express no
endogenous potassium current, were conducted. As in HEK
cells, hKv1.5vETDL currents were approximately doubled
when SAP97 was co-expressed in these cells. Peak currents
at +60 mV in CHO cells expressing hKv1.5vETDL were
1.04S 0.12 nA and 2.42S 0.17 nA when SAP97 was co-ex-
pressed. In LM cells the corresponding currents were
2.06S 0.30 nA and 3.87S 0.66 for cells expressing only
hKv1.5vETDL and hKv1.5vETDL plus SAP97, respectively.
Thus, it was con¢rmed that the SAP97-mediated increase in
Kv1.5 currents was independent of the PDZ binding motif at
the channel C-terminus. This lack of dependence of the
SAP97 e¡ect on the C-terminal acids of Kv1.5 is in stark
contrast to the results with other Kv1 channels [11,12]. A
novel regulatory mechanism must underlie the SAP97-medi-
ated increase in Kv1.5 potassium currents.
3.7. K-Actinin2 co-immunoprecipitates with both hKv1.5 and
SAP97
The pattern of SAP97 staining in the confocal imaging ex-
periments (Fig. 2) suggests that the protein might be in large
measure localized to T-tubules or to Z-disks. Occasionally, a
Fig. 5. A: SAP97 fails to increase Kv1.5vN209 peak currents. HEK293 cells stably expressing Kv1.5vN209 were used to test the e¡ect of
SAP97 co-expression on peak currents. Representative current traces are shown on the left. The bar graph illustrates the mean currents S
S.E.M. for four (SAP97) and seven (pGFP) cells. B: SAP97 increases Kv1.5vETDL peak currents. HEK293 cells stably expressing
Kv1.5vETDL were used to test the e¡ect of SAP97 co-expression on peak currents. Representative current traces (A) and mean dataSS.E.M.
(B) for nine (SAP97) and nine (pGFP) cells are presented. In both A and B, cells were transiently transfected with either empty vector
(pcDNA3)+pGFP or SAP97+pGFP and peak currents at several voltages were measured under voltage clamp in whole-cell con¢guration. The
asterisks indicate statistical signi¢cance at P6 0.01.
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similar but weaker Z-band-type staining pattern can be seen
in Kv1.5 imaging experiments as well (data not shown). One
of the major proteins at the Z-line is K-actinin2 [25], a protein
we have previously demonstrated to interact with hKv1.5 in
heterologous cells [24]. To test whether there is any potential
for a role for actinin in the SAP97^Kv1.5 interplay, co-immu-
noprecipitation of Kv1.5 with K-actinin2, and of SAP97 with
K-actinin2 was attempted from cardiac myocyte lysates. As
shown in Fig. 6, both SAP97 (Fig. 6A) and Kv1.5 (Fig. 6B)
co-immunoprecipitated well with K-actinin2. While actinin
may or may not be involved in the SAP97 enhancement of
hKv1.5 currents, it could well underlie the weak co-immuno-
precipitation of SAP97 with Kv1.5 in cardiac cells. Limited
co-association of the two proteins with Z-band K-actinin2, for
example, could be more than su⁄cient to yield the results
shown in Fig. 3A.
4. Discussion
We have recently shown that PSD95, a protein closely re-
lated to SAP97, binds both the C- and N-termini of hKv1.5
via its PDZ domains [14]. PSD95 is reportedly not expressed
in heart [17] and we wondered whether the N-terminal PDZ
binding domain in Kv1.5 had any relevance to the channel’s
regulation in that organ. For this reason, we examined the
interaction between Kv1.5 and SAP97, a PDZ protein that
is widely expressed in mammalian heart [20].
Without a doubt, SAP97 signi¢cantly increases hKv1.5 cur-
rents in heterologous cells. In this regard, our results are sim-
ilar to those reported by Murata et al. [21] using Xenopus
oocytes. At ¢rst glance, it seems surprising, therefore, that
we could ¢nd very little evidence for any direct interaction
between the two proteins. But the e¡ect of SAP97 co-expres-
sion on Kv1.5 currents is exceptional and dramatically di¡er-
ent from its known e¡ects on other Kv1 channels. Kv1.1,
Kv1.2, Kv1.3 and Kv1.4 channels are all clustered internally
by SAP97 and their surface expression is substantially reduced
[11,12]. Indeed, given this stark di¡erence in e¡ects of SAP97
on most Kv1 channels versus its e¡ect on Kv1.5, it would be
surprising if SAP97 did in fact bind Kv1.5. While Murata et
al. report that the two proteins do interact, they, like us, had
di⁄culty detecting these interactions in the heart. They were
unable to co-immunoprecipitate the two proteins from that
tissue and, importantly, their co-localization experiments em-
ployed a fairly non-speci¢c antibody directed against PSD95.
The most likely explanation for the co-localization they report
in myocytes is that they detected an overlap between Kv1.5
and a PDZ protein other than SAP97. The SAP97 distribu-
tion they report in their myocytes is unusual in that it is
concentrated at the cell surface and at the intercalated disk.
In our hands, and those of Leonoudakis et al. [20], cardiac
myocyte SAP97 staining was mainly intracellular along the
Z-disks or perhaps at T-tubules. Kv1.5, on the other hand,
was most prevalent at the intercalated disks.
How can SAP97 a¡ect Kv1.5 currents yet have no physical
interaction with the channel? It remains formally possible that
Kv1.5 and SAP97 do directly interact but that the interaction
is £eeting. We cannot exclude the possibility that phosphory-
lation or some other modi¢cation(s) of the channel or SAP97
in£uences binding. Phosphorylation at a C-terminal serine res-
idue is known to disrupt the interaction of PSD95 with Kir2.3
[26]. Similar phosphorylation inhibits K-amino-3-hydroxy-5-
methyl-isoxazole-4-propionate receptor subunit glucose recep-
tor-2 binding to the PDZ domains of GRIP but not of PICK1
[27,28]. Conceivably di¡erences in intrinsic modi¢cation rates
in various cell types could explain the markedly di¡erent re-
Fig. 6. Both Kv1.5 and SAP97 interact with K-actinin2 in rat heart. A: Co-immunoprecipitation of SAP97 with K-actinin2 from rat ventricular
extracts. Extracts from ventricular tissue were mixed with no antibody, anti-K-actinin2 or anti-SAP97. The protein^antibody complexes were
precipitated with protein A-Sepharose and subjected to Western analysis probed with anti-SAP97 (left panel) or anti-K-actinin2 (right panel).
B: Kv1.5 and K-actinin2 co-immunoprecipitate from rat cardiac extracts. Extracts from atrial or ventricular tissue were mixed with no anti-
body, anti-K-actinin2 or anti-Kv1.5. The protein^antibody complexes were precipitated with protein A-Sepharose and subjected to Western
analysis. Blots were probed with anti-K-actinin2.
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sults we obtained in co-immunoprecipitations from trans-
fected HEK cells and those obtained by Murata et al. in
COS-7 cells. Perhaps in COS-7 cells the state of the channel
is permissive of a stable SAP97-Kv1.5 interaction that is not
seen in other cell types (including heart).
But even if SAP97 does bind the Kv1.5 C-terminus under
speci¢c conditions, that fact cannot explain the lack of depen-
dence of the SAP97-mediated current enhancement on the
extreme Kv1.5 C-terminus. Indeed, it would appear that the
Kv1.5 N-terminus, or at least some part of the channel af-
fected by the N-terminus, not the C-terminus, is necessary for
the SAP97 e¡ect. This must be mediated by a di¡erent mech-
anism than is dominant with the other Kv1 channels. One
possibility is that SAP97 frees Kv1.5 to tra⁄c to the surface
by titrating away another binding protein(s). Similarly, it
could free another Kv1.5 binding protein to tra⁄c to the sur-
face, and then stabilize the channel there. SAP97 might even
a¡ect Kv1.5 processing or its transcript levels by an as yet
unidenti¢ed cascade. Any of these scenarios would be consis-
tent with our near-complete failure to detect any molecular
interaction Kv1.5 and SAP97.
We found that both Kv1.5 and SAP97 interact strongly
with K-actinin2. Thus, it is conceivable that actinin could be
involved in the SAP97 enhancement of Kv1.5 currents. For
example, K-actinin2 might serve as a bridge between the two
molecules. Indeed, SAP97 cardiac myocyte staining suggests
that SAP97 localizes to the Z-bands, structures very rich in
K-actinin2 [29], and, in occasional cells, some Kv1.5 appears
similarly distributed. It is hard to reconcile this actinin bridge
hypothesis with the failure of SAP97 and Kv1.5 to co-localize
in the majority of myocytes, however. Actinin is too small a
molecule for its length to account for a complete lack of
Kv1.5^SAP97 overlap. If actinin is involved, perhaps it is
more likely that it is titrated away from Kv1.5 by SAP97.
If, for example, actinin binding to Kv1.5 anchors the channel
in the cell interior, SAP97 binding to an overlapping site in
actinin could free the channel to tra⁄c to the cell surface.
Such a possibility would be consistent, at least, with the
known e¡ects of disruption of the cytoskeleton and K-actinin2
antisense experiments. Kv1.5 currents are greatly increased by
these treatments [24].
In summary, we have found that SAP97 has a profound
in£uence on Kv1.5 currents in heterologous cells. This e¡ect is
dependent on an intact Kv1.5 N-terminus, yet little evidence
for a direct interaction between the two proteins could be
found. Further research will be required to determine the ex-
act mechanism by which SAP97 increases Kv1.5 Kþ currents.
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